Kemik Mineral Dansitesi ile Biyokimyasal Parametreler Arasındaki İlişki

Öz

Çalışmamızda, kemik mineral dansitesi ile bazı kan parametreleri arasındaki ilişkinin incelenmesi amaçlanmıştır. Kesitsel retrospektif dizaynda olan bu çalışmaya 2018-2020 tarihleri arasında Yoncalı Fizik Tedavi ve Rehabilitasyon Hastanesi’ne başvuran hastalar dahil edilmiştir. Kronik hastalık kaydı olmayan, mevcut kan tetkikleri ve kan mineral dansitometri sonucu olan 282 kişi çalışmaya alındı. Hastaların %56,4’ünde (n:159) osteoporoz, %27,6’sında (n:78) osteopeni mevcuttu ve geri kalan %16’sı (n:45) sağlıklı bireylerden oluşmaktaydı. Yaş ortalaması incelendiğinde osteoporotik grubun 66 yıl, osteopenik grubun 61 yıl ve kontrol grubunun 59 yıl idi. Mean platelet volume (MPV) ve MPV/Plt değerleri arasında her üç grupta da anlamlı bir fark saptanmadı (p>0,05). Ayrıca üre, kreatin, Alanin transaminazın (ALT) osteoporoz (p<0,05) ile glukoz düzeylerinin osteopenik grup ile ilişkili olduğu saptandı. Aspartat transaminaz (AST), magnezyum (Mg), kalsiyum (Ca), fosfor (P), albümin, CRP, sedimentasyon, beyaz kan hücreleri (WBC), trombosit (Plt) sayılarının her üç grupta da anlamlı bir fark olmadığı saptandı (p>0,05). Ürik asit ve Trombosit Dağılım Genişliğinin (PDW) de kemik kitlesi ile ilişkili olduğu gözlendi. Kemik dansitesi yaşla ters orantılı olarak azalmaktaydı. Osteoporozun kadınlarda osteopeni ve kontrol grubuna kıyasla daha sık olduğu saptandı. D vitamininin de kemik kitlesiyle ilişkili olduğu saptandı. Kemik kitlesi azaldıkça Nötrofil Lenfosit Oranı (NLO) artmaktadır. Ancak MPV değerleri ile kemik kitlesi arasında herhangi bir ilişki saptanmadı.

Anahtar Kelimeler

• Kemik mineral dansitesi
• osteoporoz
• D vitamini
• Mean platelet volume
• Nötrofil lenfosit oranı

The Relationship Between Bone Mineral Densityand Some Blood Parameters

Öz

The aim of our study is to investigate the relationship between bone mineral density and blood cell sand vitamin D levels. Hospital between 2018-2020 were included in this cross-sectional retrospective study. 282 people who did not have a chronic disease record and who had blood tests and blood mineral densitometry results were included in the study. 56.4% (n: 159) of the patients had osteoporosis, 27.6% (n: 78) had osteopenia, and the remaining 16% (n: 45) consisted of healthy individuals. When the mean age was examined, it was 66 years in the osteoporotic group, 61 years in the osteopenic group and 59 years in the control group. There was no significant difference between the mean platelet volume (MPV) and MPV / Plt values in all three groups (p> 0.05). In addition, it was found that urea, creatine, Alanine transaminase (ALT), osteoporosis (p <0.05) and glucose levels were associated with the osteopenic group. Aspartate transaminase (AST), magnesium (Mg), calcium (Ca), phosphorus (P), albumin, CRP, sedimentation, white blood cells (WBC), platelet (Plt) counts were not found to be significantly different in all three groups (p > 0.05). It was observed that uric acid and Platelet Distribution Width (PDW) values were also associated with bone mass. Bone density decreased inversely with age. It was found that osteoporosis was more common in women (compared to osteopenia and control group). Vitamin D was also found to be associated with bone mass. As the bone mass decreases, the Neutrophil Lymphocyte Ratio (NLR) increases. However, no correlation was found between MPV values and bone mass.

Anahtar Kelimeler

• Bone mineral density
• osteoporosis
• Vitamin D
• Mean platelet volume
• Neutrophil lymphocyte ratio

Kaynakça

1. Armas LA, Recker RR. Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am. 2012;41(3):475-486. doi:10.1016/j.ecl.2012.04.006
2. Lane JM, Russell L, Khan SN. Osteoporosis. Clin Orthop Relat Res. 2000;(372):139-150. doi:10.1097/00003086-200003000-00016
3. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3):465-475. doi:10.1359/jbmr.061113
4. Dünya Sağlık Örgütü (27.10.2003). Musculoskeletal conditions affect millions, Erişim tarihi: 23.03.2021, https://www.who.int/news/item/27-10-2003-musculoskeletal-conditions-affect-millions,
5. Beeton CA, Bord S, Ireland D, Compston JE. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone. 2006;39(5):985-990. doi:10.1016/j.bone.2006.06.004
6. Ciovacco WA, Cheng YH, Horowitz MC, Kacena MA. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem. 2010;109(4):774-781. doi:10.1002/jcb.22456
7. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16 Suppl 3(Suppl 3):1-37. doi:10.4158/ep.16.s3.1
8. Holick MF. Vitamin D and bone health. J Nutr. 1996;126(4 Suppl):1159S-64S. doi:10.1093/jn/126.suppl_4.1159S

9. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis [published correction appears in Osteoporos Int. 2015 Jul;26(7):2045-7]. Osteoporos Int. 2014;25(10):2359-2381. doi:10.1007/s00198-014-2794-2
10. Akpolat V, Osteoporoz Tanısında Kullanılan Kemik Mineral Yoğunluğu Ölçüm Yöntemleri, Dicle Tıp Dergisi,2008;35(3): 216 - 220
11. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1):136. doi:10.1007/s11657-013-0136-1
12. Aspray TJ, Hill TR. Osteoporosis and the Ageing Skeleton. Subcell Biochem. 2019;91:453-476. doi:10.1007/978-981-13-3681-2_16
13. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194(2 Suppl):S3-S11. doi:10.1016/j.ajog.2005.08.047
14. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11(3):337-349. doi:10.1002/jbmr.5650110307
15. Riggs BL, Melton LJ 3rd. The prevention and treatment of osteoporosis [published correction appears in N Engl J Med. 1993 Jan 7;328(1):65; author reply 66]. N Engl J Med. 1992;327(9):620-627. doi:10.1056/NEJM199208273270908
16. Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002;18(3):529-555. doi:10.1016/s0749-0690(02)00022-8
17. Akbal A, Gökmen F, Gencer M, Inceer BS, Kömürcü E. Mean platelet volume and platelet distribution width can be related to bone mineralization. Osteoporos Int. 2014;25(9):2291-2295. doi:10.1007/s00198-014-2764-8
18. Li XS, Zhang JR, Meng SY, Li Y, Wang RT. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab. 2012;30(6):660-665. doi:10.1007/s00774-012-0362-4
19. Aypak C, Türedi Ö, Bircan MA, Civelek GM, Araz M. Association between mean platelet volume and bone mineral density in postmenopausal women. J Phys Ther Sci. 2016;28(6):1753-1758. doi:10.1589/jpts.28.1753
20. Toplak H, Wascher TC. Influence of weight reduction on platelet volume: different effects of a hypocaloric diet and a very low calorie diet. Eur J Clin Invest. 1994;24(11):778-780. doi:10.1111/j.1365-2362.1994.tb01076.x
21. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). 2007;(158):1-235.
22. Trautvetter U, Neef N, Leiterer M, Kiehntopf M, Kratzsch J, Jahreis G. Effect of calcium phosphate and vitamin D₃ supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron. Nutr J. 2014;13:6. doi:10.1186/1475-2891-13-6
23. Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004;19(8):1221-1230. doi:10.1359/JBMR.040511
24. Karakas EY, Yetisgin A, Cadirci D, Sezen H, Altunbas R, Kas F, et al. Usefulness of ceruloplasmin testing as a screening methodology for geriatric patients with osteoporosis. J Phys Ther Sci. 2016;28(1):235-239. doi:10.1589/jpts.28.235
25. Noris P, Melazzini F, Balduini CL. New roles for mean platelet volume measurement in the clinical practice?. Platelets. 2016;27(7):607-612. doi:10.1080/09537104.2016.1224828
26. Eroglu S, Karatas G. Platelet/lymphocyte ratio is an independent predictor for osteoporosis. Saudi Med J. 2019;40(4):360-366. doi:10.15537/smj.2019.4.24009
27. Boyraz İ, Çağlar H, Karakoyun A, Koç B, Gündüz R. Evaluation of Inflammation in Pathogenesis of Osteoporosis with Neutrophil Lymphocyte and Platelet-LymphocyteRatios; Türk Osteoporoz Dergisi 2015; 21 (3):159-160 doi: 10.4274/tod.046